• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项观察性研究:对肝硬化或肝细胞癌患者的腹水进行常规检查收益较低。

Routine review of ascites fluid from patients with cirrhosis or hepatocellular carcinoma is a low-yield procedure: an observational study.

作者信息

Thrall Michael J, Giampoli Ellen J

机构信息

Department of Pathology and Laboratory Medicine, The Methodist Hospital, Houston, TX, USA.

出版信息

Cytojournal. 2009 Aug 7;6:16. doi: 10.4103/1742-6413.54919.

DOI:10.4103/1742-6413.54919
PMID:19680465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2725447/
Abstract

BACKGROUND

Patients with cirrhosis develop ascites for physiologic reasons that are unrelated to malignant progression. However, physicians performing paracentesis in these patients, often send fluid to the cytology laboratory, sometimes specifically looking for hepatocellular carcinoma (HCC). We have investigated the diagnostic yield of these specimens.

MATERIALS AND METHODS

A computerized pathology database search for all ascites fluid cases submitted to the cytology laboratory at a major liver transplant center between November 2004 and April 2008 was performed. Clinical history was obtained for each case. Patients with cirrhosis, with or without HCC, were included in the study. Cytologic diagnoses were compiled and follow-up information was obtained for cases with non-negative findings.

RESULTS

A total of 167 specimens from 133 patients ranging from 29 to 85 years of age (mean 56 years) were submitted over the said time period. The causes of cirrhosis included: alcohol - 44; Hepatitis C - 30; Hepatitis B - 6; non-alcoholic steatohepatitis - 7; cryptogenic - 18; other single causes - 6; and multifactorial (alcohol and hepatitis viruses) - 22. Hepatocellular carcinoma (HCC) was present or strongly suspected in 17 patients and had been previously resected in two others. The status of fifteen patients was post liver transplant, with recurrent liver failure. Human immunodeficiency virus was present in seven patients and eight patients had a history of non hepatic malignancies. Among the specimens, 162 were negative, two had atypical lymphocytes worked up for lymphoma, and three had atypical epithelioid cells; none was positive for HCC. Immunohistochemistry demonstrated a mesothelial origin for the atypical epithelioid cells in two cases; in the third case, the patient died shortly after the specimen was collected, with no radiological evidence of HCC.

CONCLUSION

Ascites fluid cytology specimens in patients with cirrhosis, even those known or suspected to have HCC, are almost always negative. Atypical cells seen in such specimens should be treated with skepticism since the likelihood that they represent peritoneal spread of HCC is low..

摘要

背景

肝硬化患者出现腹水是由与恶性进展无关的生理原因引起的。然而,对这些患者进行腹腔穿刺术的医生常常将腹水送检细胞学实验室,有时专门查找肝细胞癌(HCC)。我们对这些标本的诊断价值进行了研究。

材料与方法

对2004年11月至2008年4月间提交至某大型肝移植中心细胞学实验室的所有腹水病例进行计算机化病理数据库检索。获取每个病例的临床病史。纳入有或无HCC的肝硬化患者进行研究。汇总细胞学诊断结果,并获取非阴性结果病例的随访信息。

结果

在上述时间段内,共提交了来自133例患者的167份标本,患者年龄在29至85岁之间(平均56岁)。肝硬化的病因包括:酒精性 - 44例;丙型肝炎 - 30例;乙型肝炎 - 6例;非酒精性脂肪性肝炎 - 7例;隐源性 - 18例;其他单一病因 - 6例;多因素(酒精和肝炎病毒) - 22例。17例患者存在或高度怀疑有肝细胞癌(HCC),另外2例此前已行切除术。15例患者为肝移植术后,伴有复发性肝衰竭。7例患者感染人类免疫缺陷病毒,8例患者有非肝恶性肿瘤病史。在这些标本中,162份为阴性,2份有非典型淋巴细胞,经检查排除淋巴瘤,3份有非典型上皮样细胞;无一例HCC阳性。免疫组化显示2例非典型上皮样细胞起源于间皮;第3例患者在标本采集后不久死亡,无HCC的影像学证据。

结论

肝硬化患者的腹水细胞学标本,即使是已知或怀疑患有HCC的患者,几乎总是阴性。对此类标本中见到的非典型细胞应持怀疑态度,因为它们代表HCC腹膜播散的可能性很低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9879/2725447/195f46228da2/CJ-06-54919-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9879/2725447/53b1d08b3232/CJ-06-54919-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9879/2725447/b4fff0c43a2b/CJ-06-54919-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9879/2725447/b5fdcfac4c31/CJ-06-54919-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9879/2725447/3964dbce2db1/CJ-06-54919-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9879/2725447/195f46228da2/CJ-06-54919-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9879/2725447/53b1d08b3232/CJ-06-54919-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9879/2725447/b4fff0c43a2b/CJ-06-54919-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9879/2725447/b5fdcfac4c31/CJ-06-54919-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9879/2725447/3964dbce2db1/CJ-06-54919-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9879/2725447/195f46228da2/CJ-06-54919-g005.jpg

相似文献

1
Routine review of ascites fluid from patients with cirrhosis or hepatocellular carcinoma is a low-yield procedure: an observational study.一项观察性研究:对肝硬化或肝细胞癌患者的腹水进行常规检查收益较低。
Cytojournal. 2009 Aug 7;6:16. doi: 10.4103/1742-6413.54919.
2
Hyperlipidemia and Nonalcoholic Steatohepatitis Predispose to Hepatocellular Carcinoma Development Without Cirrhosis.高脂血症和非酒精性脂肪性肝炎可导致无肝硬化的肝细胞癌发展。
J Clin Gastroenterol. 2019 Apr;53(4):309-313. doi: 10.1097/MCG.0000000000001062.
3
Glypican-3 and Hep Par-1 are Useful Biomarkers in the Cytologic Assessment of Ascites.磷脂酰肌醇蛋白聚糖-3和肝型脂肪酸结合蛋白1是腹水细胞学评估中的有用生物标志物。
Appl Immunohistochem Mol Morphol. 2019 Jan;27(1):65-69. doi: 10.1097/PAI.0000000000000548.
4
Hepatitis B Virus Infection can Cause Hepatocellular Carcinoma in Less Advanced Liver Cirrhosis: A Comparative Study of 142 Patients from North India.乙型肝炎病毒感染可在不太严重的肝硬化中导致肝细胞癌:对来自印度北部142例患者的比较研究
J Clin Exp Hepatol. 2013 Dec;3(4):288-95. doi: 10.1016/j.jceh.2013.08.007. Epub 2013 Sep 20.
5
Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease.α-1抗胰蛋白酶缺乏与终末期肝病患者肝细胞癌风险
World J Hepatol. 2015 Jun 8;7(10):1427-32. doi: 10.4254/wjh.v7.i10.1427.
6
Natural History of Cirrhosis: Changing Trends in Etiology Over the Years.肝硬化的自然史:多年来病因的变化趋势。
Dig Dis. 2021;39(4):358-365. doi: 10.1159/000512746. Epub 2020 Nov 3.
7
An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified?针对肝硬化患者肝细胞癌开展的积极肝移植项目:是否合理?
Clin Transplant. 1999 Dec;13(6):531-5. doi: 10.1034/j.1399-0012.1999.130615.x.
8
Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.失代偿期肝硬化成人腹水的治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 16;1(1):CD013123. doi: 10.1002/14651858.CD013123.pub2.
9
National survey of hepatocellular carcinoma in heavy drinkers in Japan.日本重度饮酒者肝细胞癌的全国性调查。
Alcohol Clin Exp Res. 2003 Aug;27(8 Suppl):32S-36S. doi: 10.1097/01.ALC.0000078605.33391.20.
10
Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.在乙型肝炎表面抗原检测不到的肝癌患者中,很大一部分存在 HBV DNA 整合到肝细胞 DNA 中而无肝硬化。
Clin Gastroenterol Hepatol. 2020 Feb;18(2):449-456. doi: 10.1016/j.cgh.2019.06.029. Epub 2019 Jun 25.

引用本文的文献

1
Metastatic Carcinoma in Effusions.积液中的转移性癌
Cytojournal. 2022 Jan 31;19:4. doi: 10.25259/CMAS_02_09_2021. eCollection 2022.
2
Pigs in a blanket: an unusual presentation of malignant ascites in prostatic adenocarcinoma.毯中猪:前列腺腺癌中恶性腹水的一种不寻常表现。
BMJ Case Rep. 2019 Nov 14;12(11):e230899. doi: 10.1136/bcr-2019-230899.
3
Use of the term atypical cells in the reporting of ascitic fluid cytology: A caveat.腹水细胞学报告中“非典型细胞”一词的使用:一则警示。

本文引用的文献

1
Management of cirrhosis and ascites.肝硬化和腹水的管理
N Engl J Med. 2004 Apr 15;350(16):1646-54. doi: 10.1056/NEJMra035021.
2
Management of adult patients with ascites due to cirrhosis.肝硬化所致腹水成年患者的管理
Hepatology. 2004 Mar;39(3):841-56. doi: 10.1002/hep.20066.
3
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.肝硬化腹水的管理:国际腹水俱乐部共识会议报告
Cytojournal. 2019 Jun 28;16:13. doi: 10.4103/cytojournal.cytojournal_37_18. eCollection 2019.
4
Authors attain comparable or slightly higher rates of citation publishing in an open access journal (CytoJournal) compared to traditional cytopathology journals - A five year (2007-2011) experience.与传统细胞病理学期刊相比,作者在开放获取期刊(《细胞杂志》)上发表文章获得的引用率相当或略高——一项为期五年(2007 - 2011年)的经验。
Cytojournal. 2014 Apr 29;11:10. doi: 10.4103/1742-6413.131739. eCollection 2014.
Hepatology. 2003 Jul;38(1):258-66. doi: 10.1053/jhep.2003.50315.
4
Sarcomatous hepatocellular carcinoma with malignant ascites. A report of two cases.
Acta Cytol. 1998 May-Jun;42(3):759-64. doi: 10.1159/000331841.
5
Effusion cytology of hepatocellular carcinoma with in situ hybridisation for human albumin.肝细胞癌的积液细胞学检查及人白蛋白原位杂交
J Clin Pathol. 1997 May;50(5):442-4. doi: 10.1136/jcp.50.5.442.
6
Cytology of hepatocellular carcinoma in serous fluids: a report of three cases.
Diagn Cytopathol. 1996 Aug;15(2):127-31. doi: 10.1002/(SICI)1097-0339(199608)15:2<127::AID-DC9>3.0.CO;2-F.
7
The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation.
Acta Cytol. 1993 Jul-Aug;37(4):483-8.
8
Effusion cytology of hepatocellular carcinoma.
Acta Cytol. 1995 Sep-Oct;39(5):893-7.
9
Ascitic fluid analysis in malignancy-related ascites.恶性肿瘤相关性腹水的腹水分析
Hepatology. 1988 Sep-Oct;8(5):1104-9. doi: 10.1002/hep.1840080521.
10
Cytopathology of clear-cell hepatocellular carcinoma in ascitic fluid.腹水液中透明细胞型肝细胞癌的细胞病理学
Acta Cytol. 1985 Sep-Oct;29(5):911-3.